Quick Answer
KIORA PHARMACEUTICALS INC reported Operating Income Loss of -$12.83 million for the year ending 2025.
- KIORA PHARMACEUTICALS INC showed a decrease of -384.5% in Operating Income Loss from 2024 to 2025.
- This data is from KIORA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), KIORA PHARMACEUTICALS INC's Operating Income Loss has declined by 56.2%.
- Historical annual values: Fiscal year 2025: -$12.83 million | Fiscal year 2024: $4.51 million | Fiscal year 2023: -$12.59 million | Fiscal year 2022: -$12.31 million | Fiscal year 2021: -$14.24 million | Fiscal year 2020: -$8.21 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: